CHONGQING PHARMACEUTICAL (GROUP) CO Oseltamivir Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Oseltamivir from India and how much does CHONGQING PHARMACEUTICAL (GROUP) CO import?

India exports Oseltamivir to 314 buyers globally worth $18.1M. CHONGQING PHARMACEUTICAL (GROUP) CO imports $650.0K (0.6% market share) with 13 shipments from CHINA.

Q: What is the average order value for CHONGQING PHARMACEUTICAL (GROUP) CO's Oseltamivir imports?

CHONGQING PHARMACEUTICAL (GROUP) CO's average Oseltamivir order value is $50.0K per consignment, based on 13 shipments totaling $650.0K.

Q: How does CHONGQING PHARMACEUTICAL (GROUP) CO compare to other Oseltamivir importers?

CHONGQING PHARMACEUTICAL (GROUP) CO ranks #9 among 314 Oseltamivir importers from India with 0.6% market share and 13 shipments.

Q: Who are the top Oseltamivir importers from India?

Top Oseltamivir importers: EVERSANA LIFE SCIENCE SERVICES ($4.4M), NATCO PHARMA (CANADA) INC ($3.0M), AMNEAL PHARMACEUTICALS, LLC (KY) ($2.4M), STRIDES PHARMA INC ($1.6M), NANJING JULY PHARMACEUTICAL TECHNOL ($1.4M).

Suresh Sormare

Oseltamivir

India Pharmaceutical Trade Intelligence

$122.6M118 Suppliers79 CountriesHS 30049099

ExportsIndia → UNITED STATES59.0%India → CHINA10.7%

ImportsBULGARIA → India$39.0K UNITED STATES → India$21.6K

#1 Supplier: NATCO PHARMA #1 Buyer: EVERSANA LIFE

CHONGQING PHARMACEUTICAL (GROUP) CO — Oseltamivir Importer #9 | $650.0K Trade Value | TransData Nexus | TransData Nexus

CHONGQING PHARMACEUTICAL (GROUP) CO — Oseltamivir Importer Profile

Pharmaceutical Importer · #9 buyer for Oseltamivir · $650.0K import value · 13 shipments · CHINA · DGFT Verified

CHONGQING PHARMACEUTICAL (GROUP) CO is the #9 importer of Oseltamivir from India with $650.0K in import value and 13 verified shipments. CHONGQING PHARMACEUTICAL (GROUP) CO holds a 0.6% market share in Oseltamivir imports based in CHINA. The company sources from 1 verified supplier across 7 formulations shipped to 1 country.

CHONGQING PHARMACEUTICAL (GROUP) CO — Oseltamivir Import Profile: Suppliers, Formulations & Sources

CHONGQING PHARMACEUTICAL (GROUP) CO — Oseltamivir import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Oseltamivir to CHONGQING PHARMACEUTICAL (GROUP) CO?

Verified from 13 customs shipment records

Supplier	Value	Shipments	% Share
NATCO PHARMA LIMITED	$650.0K	13	100.0%

CHONGQING PHARMACEUTICAL (GROUP) CO sources Oseltamivir from 1 verified Indian supplier based on 13 customs records. The primary supplier is NATCO PHARMA LIMITED accounting for 100.0% of imports.

How Does CHONGQING PHARMACEUTICAL (GROUP) CO Compare to Nearest Oseltamivir Importers?

Buyers ranked immediately above and below #9 by import value

#	Buyer

Where Does CHONGQING PHARMACEUTICAL (GROUP) CO Import Oseltamivir To?

Destination countries from 13 verified shipments

Country	Value	Shipments	Share
CHINA	$650.0K	13	100.0%

CHONGQING PHARMACEUTICAL (GROUP) CO imports Oseltamivir to 1 country. The primary destination is CHINA receiving 100.0% of shipments worth $650.0K.

What Oseltamivir Formulations Does CHONGQING PHARMACEUTICAL (GROUP) CO Import?

Formulation	Value	Shipments
OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 72384 X 10S OTHER REF CI NO: 123161APPENDIX 4R, RODTEP ENTRY NO: 10153	$150.0K	3
OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 70464X 10S OTHER REF CI NO: 123162APPENDIX 4R, RODTEP ENTRY NO: 10153	$150.0K	3
OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 72384X 10S OTHER REF CI NO: 123163APPENDIX 4R, RODTEP ENTRY NO: 10153	$150.0K	3
OSELTAMIVIR PHOSPHATE CAPSULES 75MG 10S 95136 X 10S OTHER REF CI NO: 123056APPENDIX 4R RODTEP ENTRY NO: 10153	$50.0K	1
OSELTAMIVIR PHOSPHATE CAPSULES 75MG 10S 96672 X 10S OTHER REF CI NO: 123058APPENDIX 4R RODTEP ENTRY NO: 10153	$50.0K	1
OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 72192 X 10S OTHER REF CI NO: 123055APPENDIX 4R RODTEP ENTRY NO: 10153	$50.0K	1
OSELTAMIVIR PHOSPHATE CAPSULES 75MG 10S 97248 X 10S OTHER REF CI NO: 123057APPENDIX 4R RODTEP ENTRY NO: 10153	$50.0K	1

CHONGQING PHARMACEUTICAL (GROUP) CO imports 7 distinct Oseltamivir formulations from India. The top formulation is OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 72384 X 10S OTHER RE with 3 shipments worth $150.0K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Oseltamivir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: CHONGQING PHARMACEUTICAL (GROUP) CO matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as CHONGQING PHARMACEUTICAL (GROUP) CO's capped import value divided by total capped export value for Oseltamivir across all Indian exporters.
5.Verified Records: This page is backed by 13 individual customs records matching CHONGQING PHARMACEUTICAL (GROUP) CO importing Oseltamivir, covering 7 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 79+ countries, 314+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Oseltamivir

Oseltamivir

CHONGQING PHARMACEUTICAL (GROUP) CO — Oseltamivir Importer Profile

CHONGQING PHARMACEUTICAL (GROUP) CO — Oseltamivir Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Oseltamivir to CHONGQING PHARMACEUTICAL (GROUP) CO?

How Does CHONGQING PHARMACEUTICAL (GROUP) CO Compare to Nearest Oseltamivir Importers?

Where Does CHONGQING PHARMACEUTICAL (GROUP) CO Import Oseltamivir To?

What Oseltamivir Formulations Does CHONGQING PHARMACEUTICAL (GROUP) CO Import?

Who Are the Top Buyers of Oseltamivir from India and How Much Does CHONGQING PHARMACEUTICAL (GROUP) CO Import?

What Is the Average Order Value for CHONGQING PHARMACEUTICAL (GROUP) CO's Oseltamivir Imports?

Who Supplies Oseltamivir to CHONGQING PHARMACEUTICAL (GROUP) CO?

How Does CHONGQING PHARMACEUTICAL (GROUP) CO Compare to Other Oseltamivir Importers?

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Oseltamivir Import Data for CHONGQING PHARMACEUTICAL (GROUP) CO

CHONGQING PHARMACEUTICAL (GROUP) CO × Oseltamivir

Related Analysis

Need Detailed Import Data?

Data Source

7	NANJING JULY PHARMACEUTICAL TECHNOL	CHINA	$1.4M	27	$50.0K
6	J. KNIPPER & COMPANY	UNITED STATES	$1.0M	20	$50.0K
9	CHONGQING PHARMACEUTICAL (GROUP) CO ★	CHINA	$700.0K	14	$50.0K
17	STRIDES PHARMA INC,	UNITED STATES	$700.0K	14	$50.0K
15	CHONGQING PHARMACEUTICAL GROUP	CHINA	$650.0K	13	$50.0K